BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/23/2021 6:43:04 AM | Browse: 711 | Download: 1863
 |
Received |
|
2021-05-10 03:09 |
|
Peer-Review Started |
|
2021-05-10 03:12 |
|
First Decision by Editorial Office Director |
|
2021-06-05 13:59 |
|
Return for Revision |
|
2021-06-05 13:59 |
|
Revised |
|
2021-06-18 23:32 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-07-12 03:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-07-12 06:30 |
|
Articles in Press |
|
2021-07-12 06:30 |
|
Edit the Manuscript by Language Editor |
|
2021-07-21 06:55 |
|
Typeset the Manuscript |
|
2021-08-20 03:25 |
|
Publish the Manuscript Online |
|
2021-08-23 06:43 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Guillermo Arturo Valencia, Patricia Rioja, Zaida Morante, Jhajaira M Araujo, Heberth Daniel Vallejos, Henry Guerra and Henry L Gomez |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guillermo Arturo Valencia, MD, Medical Assistant, Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Angamos Este Avenue 2520. Surquillo, Lima 15000, Peru. guillermo.valencia.mesias@gmail.com |
| Key Words |
Triple-negative breast cancer; PIK3CA mutation; Liquid biopsy; Early relapse; Biomarker; Case report |
| Core Tip |
This case report evaluates the detection of PIK3CA mutation in liquid biopsy and tumor tissue in a patient with locally-advanced triple-negative breast cancer after receiving conventional oncological therapy and its association with early relapse and progression disease. This case highlights the importance of detecting the PIK3CA mutation as a potential biomarker of early relapse. In addition, the PIK3CA mutation could lead to additional interventions to detect metastatic disease earlier in the follow-up. There is limited information of liquid biopsy studies after surgery. Furthermore, there is very limited data about trials of PIK3CA mutations in Peruvian patients with non-metastatic breast cancer. |
| Publish Date |
2021-08-23 06:43 |
| Citation |
Valencia GA, Rioja P, Morante Z, Araujo JM, Vallejos HD, Guerra H, Gomez HL. PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report. World J Clin Oncol 2021; 12(8): 702-711 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i8/702.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i8.702 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
